The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. (2008)
Attributed to:
Adult HIV Clinical Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
PubMed Identifier: 18505180
Publication URI: http://europepmc.org/abstract/MED/18505180
Type: Journal Article/Review
Volume: 13
Parent Publication: Antiviral therapy
Issue: 2
ISSN: 1359-6535